2021 Highlights

Montefiore Einstein Neurological Sciences

Comprising the Saul R. Korey Department of Neurology and the Leo M. Davidoff Department of Neurological Surgery, our Neurological Sciences Program is driven by a shared mission to provide comprehensive, multidisciplinary care for patients with disorders affecting the nervous system, including the brain, spinal cord and peripheral nerves. Each department endeavors to improve service and optimize the patient journey using a patient-centered approach, engage in high-impact translational research and participate in the education and mentorship of students, residents, fellows and faculty. 


2021 by the numbers


Increase in neurology outpatient visits since 2017


Increase in neurosurgery outpatient visits since 2017


Increase in neurology admissions since 2017


Neurosurgical procedures over last four years


Notable innovations and achievements by Montefiore Einstein Neurological Surgery

An ongoing commitment to research and mentorship

Founded in 2012 and currently led by Emad N. Eskandar, MD, the Neurosurgeon Research Career Development Program (NRCDP) is an NIH-funded K12 program whose mission is to develop a cadre of diverse neurosurgeon scientists at institutions throughout the country. In the nine years since its inception, the highly successful and expanding program has reviewed applications from 125 individuals at 60 different institutions and has supported 26 scholars. 

In a recent review, it was discovered that 85% of NRCDP scholars successfully obtained subsequent independent federal funding and continue to lead active, productive research efforts as neurosurgeon-scientists. This ethos animates the faculty, residents and students in the Departments of Neurology and Neurosurgery who collectively strive to improve patient outcomes through basic, translational and clinical research.

Research Review

Improving care and outcomes through research

Over the course of 2020 and into 2021, Montefiore Einstein Neurological Sciences published widely on a variety of topics.

Explore our latest



Advancing neurological care through clinical trials

Our scientists and researchers are paving the way for novel treatments and diagnostic breakthroughs through our innovative clinical research, which includes work in cerebrovascular diseases, epilepsy, migraine, sleep wake disorders and more.

NIH Strokenet for Acute Interventional Stroke Trials

Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine

Statins In Intracerbral Hemorrhage (SATURN)

A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

An Open Label Study of FT218 in Subjects With Narcolepsy (RESTORE)

Michael J. Thorpy, MD

Reduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies

Richard B. Lipton, MD

Atogepant for the Preventive Treatment of Migraine

Richard B. Lipton, MD

Patient-identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient-centered outcome

Richard B. Lipton, MD

Efficacy of erenumab in chronic migraine patients with and without ictal allodynia

Richard B. Lipton, MD

Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study

Richard B. Lipton, MD

Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant

Richard B. Lipton, MD

Safety and efficacy of ubrogepant in participants with major cardiovascular risk factors in two single-attack phase 3 randomized trials: ACHIEVE I and II

Richard B. Lipton, MD

Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene-related peptide-targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug-drug interaction study

Richard B. Lipton, MD

Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial

Richard B. Lipton, MD

Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension

Richard B. Lipton, MD

Advancing neurological surgery care through clinical trials

Through innovative clinical research, our scientists and researchers are at the forefront of discovery, offering breakthroughs in atypical meningiomas and pituitary adenoma. Faculty in the Department of Neurological Surgery are involved in nearly 80 research protocols studying a broad range of disorders, including neurovascular disease, epilepsy, movement disorders, spinal disease, brain tumors and neurosurgical disorders affecting infants and children.

US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair (NECC)

David Altschul, MD 

The Cerus contour device is a new endosaccular flow disruptor designed to treat wide-necked bifurcation aneurysms. Historically, aneurysms in this location have been treated with open surgical clipping or stent-assisted coiling, which requires the need of long-term dual antiplatelet therapy. The Cerus contour device offers a minimally invasive alternative without the need for long-term antiplatelet therapy. Montefiore is one of a handful of select hospitals in the country participating in the trial designed to study the safety and efficacy of the device. If you have any questions or potential candidates, please contact Dr. David Altschul.

The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma (STEM) (STEM)

Chronic subdural hematoma is a common disease that affects elderly patients. Traditional treatment involves surgical evacuation; however, these treatments come with a high complication rate, including the need for multiple surgeries. Minimally invasive treatments have been discovered in the form of middle meningeal artery embolization. Montefiore is one of some 20 centers in the country assessing the safety and efficacy of patients with middle meningeal artery embolization with or without surgery for the treatment of chronic subdural hematoma. If you have any questions or potential candidates, please contact Dr. David Altschul.

A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Safety and Efficacy of IGV-001, an Autologous Cell Immunotherapy With Antisense Oligonucleotide (IMV-001) Targeting IGF1R...

The purpose of this study is to assess progression-free survival (PFS) and overall survival (OS) in newly diagnosed glioblastoma multiforme (GBM) participants treated with IGV-001 as compared with placebo. If you have any questions or potential candidates, please contact Dr. Vijay Agarwal.

Intractable Migraine Study

David Altschul, MD

Intractable migraine disorder is a serious illness that affects many young people and impacts their ability to work and participate in society. We are researching the theory that the cause of this illness is vascular in nature, due to an imbalance of the vasomotor tone of the extracranial vasculature. We are currently in the study’s first phase: recruiting patients and injecting vasodilator medications into these arteries to prove migraine headaches can be triggered. Once proved, we can then move to the next phase of the study, which will be to embolize these arteries as a potential modality for treatment.


Basic and translational research

The Department of Neurological Surgery includes four outstanding scientists performing translational research to develop new understandings of specific neurological conditions. This research is aimed at understanding the basis of cognition and its impairment in Parkinson disease, understanding the mechanisms underlying learning and their derangement in substance use or behavioral addictions, developing neural prosthetics for the treatment of blindness and developing a better understanding of the biology and immunology of glioblastoma in an effort to develop more effective treatments.

Team News

Updates and additions to our Neurology faculty

Perveen K. Chattha, MD

Attending Physician, Neurology
Assistant Professor, Neurology

Amina Khalid, MD

Attending Physician, Neurology
Assistant Professor, Neurology

Oleg Otlivanchik, MD, PhD

Attending Physician, Department of Neurology
Attending Physician, Stern Stroke Center
Stroke Neurohospitalist Liaison

Ji-ae Lee, MD

Attending Physician, Neurology

Team News

Updates and additions to our Neurological Surgery faculty

Celina M. Crisman, MD, MPH

Attending Physician
Assistant Professor, Leo M. Davidoff Department of Neurological Surgery

Yaroslav (Jacob) Gelfand, MD

Attending Physician
Assistant Professor, Leo M. Davidoff Department of Neurological Surgery

Saikiran Murthy, DO

Attending Physician
Assistant Professor, Leo M. Davidoff Department of Neurological Surgery

Jinan Behnan, PhD

Assistant Professor, Leo M. Davidoff Department of Neurological Surgery

Patient referrals

At Montefiore Einstein, we know providing patients with the best possible care includes teamwork and trust. We work closely with our valued referring physicians to ensure open communication and reliable expertise

Contact us

Mark F. Mehler MD, Chair, Neurology


Emad Eskandar MD, MBA, Chair, Neurological Surgery

Montefiore Einstein Neurology
Montefiore Einstein Neurological Surgery